Keyphrases
Perinatal Outcome
83%
Antiphospholipid Antibodies
83%
Pregnant Women
65%
Confidence Interval
63%
Lupus Anticoagulant
54%
Adjusted Odds Ratio
49%
Antiphospholipid Syndrome
44%
Middle Cerebral Artery Doppler
41%
International Congresses
41%
Interpregnancy Interval
41%
Prenatal Cannabis Exposure
41%
Cannabis Use
41%
Task Force Report
41%
Thrombotic Markers
41%
COVID-19
41%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
41%
Maternal Referral System
41%
Placenta Accreta Spectrum
41%
Outpatient Ripening
41%
Composite Neonatal Morbidity
41%
Iron Deficiency
41%
Intravenous Iron
41%
Anemia
41%
Amniotic Fluid
41%
Rhesus Macaque
41%
Anti-phosphatidylserine/prothrombin
41%
Adverse Pregnancy Outcomes
41%
Immunoglobulin G
31%
Maternal Anemia
27%
Low Molecular Weight Iron Dextran
27%
Iron Sucrose
27%
Gnathostomes
26%
D-dimer
23%
Non-associated
21%
Universal Type
20%
Retrospective Cohort Study
20%
Neonatal Outcome
18%
Balloon Ripening
16%
Thrombosis
16%
During Pregnancy
16%
Previous Cesarean Delivery
15%
Odds Ratio
15%
Obstetrical Emergency
13%
Antepartum
13%
Intravenous Infusion
13%
Anaemia Status
13%
Intravenous Iron Therapy
13%
Ferric Carboxymaltose
13%
Maternal Outcomes
13%
Iron Deficient
13%
Medicine and Dentistry
Anemia
100%
Iron Deficiency
83%
Antiphospholipid Antibody
83%
Odds Ratio
54%
Disease
53%
Antiphospholipid Syndrome
44%
Lupus Anticoagulant
43%
Cerclage
41%
Middle Cerebral Artery
41%
Health Care Cost
41%
Infection
41%
Placenta Accreta
41%
Cannabis Use
41%
Adjuvant Therapy
41%
Meta-Analysis
41%
Obstetrics
41%
Severe Acute Respiratory Syndrome Coronavirus 2
41%
Systematic Review
41%
Cervical Cerclage
41%
Consultation
41%
Patient Referral
41%
Hematology
41%
Iron
41%
Thrombocytopenia
41%
Complication of Pregnancy
41%
Procoagulant
41%
Amnion Fluid
41%
Prothrombin
41%
Immunoglobulin G
31%
Antibiotics
27%
Blood Sampling
23%
Randomized Controlled Trial
23%
Bleeding
22%
Cesarean Section
20%
Thromboembolism
20%
Blood Disorder
16%
Venous Thromboembolism
16%
D-Dimer
15%
Pre-Eclampsia
14%
Maternal Morbidity
14%
Cohort Analysis
13%
Iron Sucrose
13%
Iron Dextran
13%
Retrospective Cohort Study
13%
Newborn Mortality
13%
Premature Labor
13%
Thrombosis
12%
Systemic Lupus Erythematosus
12%
Erythrocyte
11%
Odds Ratio
9%